PowerPoint 프레젠테이션

Download Report

Transcript PowerPoint 프레젠테이션

The information contained in this presentation shall not be shared or furnished without prior written consent by Hyundai Pharm
This is the mark given by the government for
selected innovative companies
100
50
0
CATERIA
PRODUCTS
ACTION
INDICATION
DEVELOPMENT STATUS
Aripiprazole
IR
Antipsychotics
Acute manic and mixed
episodes associated
with bipolar disorder
Launch ready
(expected in Feb, 2014)
Donepezil HCl
SR
Anticholinesterases
Dementia from
Alzheimer’s disease
Finished the formulation study
Antiepileptics
Epilepsy
TCA
Depression
SR
Levetiracetam
Finished the formulation study
IR
Mirtazapine
IR
SR
Pramipexole HCl
Dopamine agonists
Parkinson’s Disease
IR
Oncology
SR
Launch ready
(expected in May, 2013)
Phase I ready
Parasympathomimetic
Cognitive disorder
IR
Lacosamide
Launch ready
(expected in Dec, 2012)
BE ready
SR
Choline alfoscerate
Launch ready
(expected in Jan, 2013)
BE ready
voltage-gated sodium
channels
epilepsy
Pre Clinical
Phenylpiperidine
derivative
Narcotic analgesic
In fomulation Study
Fentanyl citrate
trans
mucosal
Acebrophylline
SR
Muco-active
Respiratory disease
Phase I
Levodropropizine
SR
peripheral antitussive
Cough
Launch ready
Imatinib mesylate
Mini-tablet
tyrosine kinase
inhibitor
chronic myelogenous
leukemia
In fomulation Study
CATERIA
PRODUCTS
Ibandronate
IR
ACTION
INDICATION
DEVELOPMENT STATUS
Bisphosphonate
Osteoporosis
Launched in August, 2012
Telmisartan + HCTZ
COM
Angiotensin II
antagonist
Hypertension
Finished the formulation study
Valsartan + Amlodipine
COM
Angiotensin II
antagonist
Hypertension
Launch Ready
(In process of product approval)
Tamsulosin
CR / OD
Alpha adrenoreceptor
antagonist
BPH
BE Ready
Dutasteride
Weekly
5-alpha-reductase
inhibitor
Alopecia
Pre Clinical
COM
Antiulcerant Mucosal
protection
Gastroduodenal
Ulcer
Pre Clinical
OD
proton pump inhibitor
gastro esophageal
reflux disease
In fomulation Study
antibiotic+retinoid
Mild to moderate
acne
Pre Clinical
Synthetic derivative of
the amino acid
Whitening
In fomulation Study
Ecabet + Ranitidine
Esomeprazole
Clindamycin+Adapalene
HOB-060
COM
Topical